The company is focused on developing spinal fusion products for treating degenerative disc disease. The company was able to experience success, despite an 8 percent decline in the number of spinal fusions for DDD performed in the United States.
Related Articles on Spine Devices:
26 Spine Devices Receive FDA 510(k) Clearance in December
5 Spine-Driven Device Company Financial Reports
14 Spine Device Company Executive Moves
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
